# Sunitinib Tumor Levels in Patients Not on Enzyme-Inducing Anti-Epileptic Drugs Undergoing Debulking Surgery for Recurrent Glioblastoma

> **NCT00864864** · EARLY_PHASE1 · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 8 (actual)

## Conditions studied

- Glioblastoma
- Brain Tumor

## Interventions

- **DRUG:** Sunitinib

## Key facts

- **NCT ID:** NCT00864864
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-05
- **Primary completion:** 2011-05
- **Final completion:** 2013-05
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2016-07-07

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00864864

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00864864, "Sunitinib Tumor Levels in Patients Not on Enzyme-Inducing Anti-Epileptic Drugs Undergoing Debulking Surgery for Recurrent Glioblastoma". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00864864. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*